Your browser doesn't support javascript.
loading
Cryo-EM structures reveal two allosteric inhibition modes of PI3KαH1047R involving a re-shaping of the activation loop.
Huang, Xiuliang; Wang, Kailiang; Han, Jing; Chen, Xiumei; Wang, Zhenglin; Wu, Tianlun; Yu, Bo; Zhao, Feng; Wang, Xinjuan; Li, Huijuan; Xie, Zhi; Zhu, Xiaotian; Zhong, Wenge; Ren, Xiaoming.
Afiliação
  • Huang X; Regor Therapeutics Group, Shanghai 201210, China. Electronic address: xiuliang.huang@qlregor.com.
  • Wang K; Regor Therapeutics Group, Shanghai 201210, China.
  • Han J; Regor Therapeutics Group, Shanghai 201210, China.
  • Chen X; Regor Therapeutics Group, Shanghai 201210, China.
  • Wang Z; Regor Therapeutics Group, Shanghai 201210, China.
  • Wu T; Regor Therapeutics Group, Shanghai 201210, China.
  • Yu B; Regor Therapeutics Group, Shanghai 201210, China.
  • Zhao F; Regor Therapeutics Group, Shanghai 201210, China.
  • Wang X; Regor Therapeutics Group, Shanghai 201210, China.
  • Li H; Regor Therapeutics Group, Shanghai 201210, China.
  • Xie Z; Regor Therapeutics Group, Cambridge, MA 02142, USA.
  • Zhu X; Regor Therapeutics Group, Cambridge, MA 02142, USA.
  • Zhong W; Regor Therapeutics Group, Shanghai 201210, China.
  • Ren X; Regor Therapeutics Group, Shanghai 201210, China. Electronic address: xiaoming.ren@qlregor.com.
Structure ; 32(7): 907-917.e7, 2024 Jul 11.
Article em En | MEDLINE | ID: mdl-38582077
ABSTRACT
PI3Kα is a lipid kinase that phosphorylates PIP2 and generates PIP3. The hyperactive PI3Kα mutation, H1047R, accounts for about 14% of breast cancer, making it a highly attractive target for drug discovery. Here, we report the cryo-EM structures of PI3KαH1047R bound to two different allosteric inhibitors QR-7909 and QR-8557 at a global resolution of 2.7 Å and 3.0 Å, respectively. The structures reveal two distinct binding pockets on the opposite sides of the activation loop. Structural and MD simulation analyses show that the allosteric binding of QR-7909 and QR-8557 inhibit PI3KαH1047R hyper-activity by reducing the fluctuation and mobility of the activation loop. Our work provides a strong rational basis for a further optimization and development of highly selective drug candidates to treat PI3KαH1047R-driven cancers.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microscopia Crioeletrônica / Simulação de Dinâmica Molecular Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microscopia Crioeletrônica / Simulação de Dinâmica Molecular Idioma: En Ano de publicação: 2024 Tipo de documento: Article